iBio, Inc. (IBIO) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	100.0K	100.0K	400.0K	225.0K	—
Cost of Revenue	—	—	—	—	—
Gross Profit	100.0K	100.0K	400.0K	225.0K	—
Operating Expenses
R&D Expense	19.6M	19.6M	8.3M	5.2M	10.3M
SG&A Expense	10.6M	10.6M	10.7M	11.7M	18.5M
General & Admin Expense	10.6M	10.6M	10.7M	11.7M	18.5M
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	5.0M	5.0M	—	—	565.0K
Total Operating Expenses	35.2M	35.2M	19.0M	16.9M	29.3M
Cost and Expenses	35.2M	35.2M	19.0M	16.9M	29.3M
Operating Income (EBIT)	(35.1M)	(35.1M)	(18.6M)	(16.6M)	(29.3M)
Non-Operating
Interest Income	2.1M	2.1M	437.0K	363.0K	213.0K
Interest Expense	53.0K	53.0K	212.0K	172.0K	83.0K
Net Interest Income	2.1M	2.1M	225.0K	191.0K	130.0K
Other Non-Op Income/Expense	2.1M	2.1M	225.0K	1.2M	32.0K
Non-Operating Income (excl Interest)	(2.1M)	(2.1M)	(437.0K)	(1.4M)	(115.0K)
EBT (Pre-Tax Income)	(33.0M)	(33.0M)	(18.4M)	(15.4M)	(29.3M)
Income Tax Expense	—	—	—	—	—
Bottom Line
Net Income	(33.0M)	(33.0M)	(18.4M)	(24.9M)	(65.0M)
Earnings from Cont. Ops	(33.0M)	(33.0M)	(18.4M)	(15.4M)	(29.3M)
Earnings from Discont. Ops	—	—	—	(9.5M)	(35.7M)
Bottom Line Net Income	(33.0M)	(33.0M)	(18.4M)	(24.9M)	(65.0M)
Per Share
Basic EPS	($0.33)	($0.32)	($1.75)	($6.50)	($106.18)
Diluted EPS	($0.33)	($0.32)	($1.75)	($6.50)	($106.18)
Revenue Per Share	$0.00	$0.00	$0.04	$0.06	$0.00
Shares
Basic Shares Outstanding	104.1M	104.1M	10.5M	3.8M	612250
Diluted Shares Outstanding	104.1M	104.1M	10.5M	3.8M	612250
Profitability Metrics
EBITDA	(32.3M)	(32.3M)	(17.0M)	(14.0M)	(27.8M)
D&A	646.0K	646.0K	1.1M	1.3M	1.4M
EBIT	(33.0M)	(33.0M)	(18.2M)	(15.3M)	(29.2M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026